PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24327273-6	2014	In addition, in the EML4-ALK-driven mouse lung adenocarcinoma model, HSP90 inhibition can overcome both primary and acquired crizotinib resistance.	Crizotinib	125-135	heat shock protein 86, pseudogene 1	Mus musculus	69-74	
24327273-7	2014	Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.	Crizotinib	164-174	heat shock protein 86, pseudogene 1	Mus musculus	13-18